140 related articles for article (PubMed ID: 35880605)
1. Using health insurance claims data to assess long-term disease progression in a prostate cancer cohort.
Khan S; Vohra S; Farnan L; Elmore SNC; Toumbou K; K C M; Fontham ETH; Peters ES; Mohler JL; Bensen JT
Prostate; 2022 Nov; 82(15):1447-1455. PubMed ID: 35880605
[TBL] [Abstract][Full Text] [Related]
2. The North Carolina-Louisiana Prostate Cancer Project (PCaP): methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes.
Schroeder JC; Bensen JT; Su LJ; Mishel M; Ivanova A; Smith GJ; Godley PA; Fontham ET; Mohler JL
Prostate; 2006 Aug; 66(11):1162-76. PubMed ID: 16676364
[TBL] [Abstract][Full Text] [Related]
3. Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC.
Allott EH; Farnan L; Steck SE; Song L; Arab L; Su LJ; Fontham ETH; Mohler JL; Bensen JT
Prostate; 2018 Aug; 78(11):857-864. PubMed ID: 29717502
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer aggressiveness and financial toxicity among prostate cancer patients.
Kc M; Oral E; Rung AL; Trapido E; Rozek LS; Fontham ETH; Bensen JT; Farnan L; Steck SE; Song L; Mohler JL; Khan S; Vohra S; Peters ES
Prostate; 2023 Jan; 83(1):44-55. PubMed ID: 36063402
[TBL] [Abstract][Full Text] [Related]
5. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
6. Disease and Treatment Characteristics of Men Diagnosed With Metastatic Hormone-Sensitive Prostate Cancer in Real Life: Analysis From a Commercial Claims Database.
Flaig TW; Potluri RC; Ng Y; Todd MB; Mehra M; Higano CS
Clin Genitourin Cancer; 2017 Apr; 15(2):273-279.e1. PubMed ID: 27876504
[TBL] [Abstract][Full Text] [Related]
7. How does health literacy affect quality of life among men with newly diagnosed clinically localized prostate cancer? Findings from the North Carolina-Louisiana Prostate Cancer Project (PCaP).
Song L; Mishel M; Bensen JT; Chen RC; Knafl GJ; Blackard B; Farnan L; Fontham E; Su LJ; Brennan CS; Mohler JL; Godley PA
Cancer; 2012 Aug; 118(15):3842-51. PubMed ID: 22180041
[TBL] [Abstract][Full Text] [Related]
8. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
Nair B; Wilt T; MacDonald R; Rutks I
Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
[TBL] [Abstract][Full Text] [Related]
9. Neighborhood deprivation and risk of mortality among men with prostate cancer: Findings from a long-term follow-up study.
K C M; Oral E; Rung AL; Trapido EJ; Rozek LS; Fontham ETH; Bensen JT; Farnan L; Steck SE; Song L; Mohler JL; Peters ES
Prostate; 2022 May; 82(7):783-792. PubMed ID: 35201637
[TBL] [Abstract][Full Text] [Related]
10. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
11. Calcium, magnesium, and whole-milk intakes and high-aggressive prostate cancer in the North Carolina-Louisiana Prostate Cancer Project (PCaP).
Steck SE; Omofuma OO; Su LJ; Maise AA; Woloszynska-Read A; Johnson CS; Zhang H; Bensen JT; Fontham ETH; Mohler JL; Arab L
Am J Clin Nutr; 2018 May; 107(5):799-807. PubMed ID: 29722851
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with the use of complementary and alternative medicines for prostate cancer by long-term survivors.
Egger S; Hughes S; Smith DP; Chambers S; Kahn C; Moxey A; O'Connell DL
PLoS One; 2018; 13(3):e0193686. PubMed ID: 29513724
[TBL] [Abstract][Full Text] [Related]
15. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities.
Baade PD; Aitken JF; Ferguson M; Gardiner RA; Chambers SK
BMC Cancer; 2010 Aug; 10():452. PubMed ID: 20731875
[TBL] [Abstract][Full Text] [Related]
17. Psychometric Evaluation of PROMIS Sexual Function and Satisfaction Measures in a Longitudinal Population-Based Cohort of Men With Localized Prostate Cancer.
Reeve BB; Wang M; Weinfurt K; Flynn KE; Usinger DS; Chen RC
J Sex Med; 2018 Dec; 15(12):1792-1810. PubMed ID: 30539735
[TBL] [Abstract][Full Text] [Related]
18. Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.
Goldsbury DE; Smith DP; Armstrong BK; O'Connell DL
BMC Health Serv Res; 2011 Oct; 11():253. PubMed ID: 21978077
[TBL] [Abstract][Full Text] [Related]
19. Design of the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS).
Chen RC; Carpenter WR; Kim M; Hendrix LH; Agans RP; Meyer AM; Hoffmeyer A; Reeve BB; Nielsen ME; Usinger DS; Strigo TS; Jackman AM; Anderson M; Godley PA
J Comp Eff Res; 2015 Jan; 4(1):3-9. PubMed ID: 25565065
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of probable depression in prostate cancer survivors.
Erim DO; Bensen JT; Mohler JL; Fontham ETH; Song L; Farnan L; Delacroix SE; Peters ES; Erim TN; Chen RC; Gaynes BN
Cancer; 2019 Oct; 125(19):3418-3427. PubMed ID: 31246284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
